Icure Pharmaceutical Incorporation (KOSDAQ: 175250)

Market Cap	66.11B
Revenue (ttm)	60.61B
Net Income (ttm)	521.32M
Shares Out	37.37M
EPS (ttm)	13.88
PE Ratio	127.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	97,972
Average Volume	114,933
Open	1,809.00
Previous Close	1,769.00
Day's Range	1,739.00 - 1,809.00
52-Week Range	1,660.00 - 3,490.00
Beta	1.07
RSI	39.80
Earnings Date	Mar 21, 2025

About Icure Pharmaceutical Incorporation

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers functional, nature-derived, derma, and customized cosmetics products. It also offers eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. In addition, the company provides body and haircare products, including naturally derived hair and baby line, cleansing tissue, and wet wipes. Further, it offers perfumes, textile perfu...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2000
• Employees: 218
• Stock Exchange: KOSDAQ
• Ticker Symbol: 175250

Financial Performance

In 2023, Icure Pharmaceutical Incorporation's revenue was 56.81 billion, a decrease of -4.31% compared to the previous year's 59.37 billion. Losses were -31.42 billion, -24.77% less than in 2022.